Exploring the therapeutic potential of targeting the increased mitophagy observed in the FBXL4-associated MTDPS13 disorder, an incurable disease at present, is an area of significant interest. The gene discussed is FBXL4; the disease is mitochondrial DNA depletion syndrome 13.